Ming‐Min Chang

456 citations
22 papers · 372 · h-index 12

Impact in

Papers in

    • Fibroblast Growth Factor Research 4
    • Epigenetics and DNA Methylation 4
    • Kruppel-like factors research 3
    • Cell death mechanisms and regulation 2
    • Protease and Inhibitor Mechanisms 3

Ming‐Min Chang

22 papers receiving 365 citations

Peers

Ming‐Min Chang
Comparison fields: 5 of 73
  • Pharmacology 72
  • Cancer Research 47
  • Complementary and alternative medicine 26
  • Geriatrics and Gerontology 9
  • Pharmacology 22
Replace Jixiang Xu with:
Jixiang Xu China
Mengfan Liu China
Xiaopeng Song China
Xiao Ni China
Yuyang Zheng China
Chen‐Chen Lee Taiwan
Brandie N. Radde United States
Gudrun Reiterer United States
Fawaz Al‐Mousa United Kingdom
Ming‐Min Chang relative to Jixiang Xu China Jixiang Xu's profile →
Citations per field
00.5×2×3.3×
Jixiang Xu · 1×
Citations per year

Countries citing papers authored by Ming‐Min Chang

Since Specialization
Citations

This map shows the geographic impact of Ming‐Min Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Min Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Min Chang more than expected).

Fields of papers citing papers by Ming‐Min Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Min Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Min Chang. The network helps show where Ming‐Min Chang may publish in the future.

Co-authors

The 25 scholars most cited alongside Ming‐Min Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ming‐Min Chang Line = papers co-authored together Ming‐Min Chang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#Work
1 201661
2 202138
3 201737
4 201836
5 202035
6 202128
7 201919
8 201917
9 201816
10 199415
11 201912
12 201812
13 202111
14 201911
15 19956
16 20204
17 20233
18
FGF9 promotes cell proliferation and tumorigenesis in TM3 mouse Leydig progenitor cells.
20223
19 20233
20 20252

About Ming‐Min Chang

Ming‐Min Chang is a scholar working on Molecular Biology, Cancer Research, Oncology, Epidemiology and Cell Biology, having authored 22 papers that have together received 372 indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (4 papers), Epigenetics and DNA Methylation (4 papers), Kruppel-like factors research (3 papers), Protease and Inhibitor Mechanisms (3 papers), Aluminum toxicity and tolerance in plants and animals (2 papers), Cell death mechanisms and regulation (2 papers), Cell Adhesion Molecules Research (2 papers) and Folate and B Vitamins Research (1 paper). The work is most often cited by research in Pharmacology (72 citations), Cancer Research (47 citations), Complementary and alternative medicine (26 citations), Geriatrics and Gerontology (9 citations) and Pharmacology (22 citations). Ming‐Min Chang has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Bu‐Miin Huang, Chia‐Yih Wang, Yung‐Chia Chen, Shang‐Hsun Yang, Chia‐Ching Wu, Ying-Hui Chen, Bo‐Syong Pan, J.L. Greger, Hung-Chi Cheng and Wen‐Tsan Chang. Their work appears in journals such as International Journal of Molecular Sciences, Journal of Hematology & Oncology, Stem Cell Research & Therapy, Cancer Medicine and Toxicology and Applied Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact